LiveRamp Holdings, Inc. (NYSE:RAMP – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $39.83.
RAMP has been the subject of a number of research analyst reports. Benchmark reaffirmed a “buy” rating and set a $45.00 price objective on shares of LiveRamp in a research report on Wednesday, February 26th. StockNews.com raised shares of LiveRamp from a “buy” rating to a “strong-buy” rating in a report on Sunday, December 22nd. Morgan Stanley increased their price target on shares of LiveRamp from $35.00 to $38.00 and gave the company an “equal weight” rating in a report on Thursday, February 6th. Finally, Evercore ISI boosted their price objective on LiveRamp from $40.00 to $45.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th.
Read Our Latest Research Report on LiveRamp
Insider Buying and Selling at LiveRamp
Institutional Trading of LiveRamp
A number of institutional investors and hedge funds have recently made changes to their positions in RAMP. American Capital Management Inc. lifted its holdings in shares of LiveRamp by 46.7% in the third quarter. American Capital Management Inc. now owns 2,877,814 shares of the company’s stock worth $71,312,000 after acquiring an additional 916,578 shares during the last quarter. Tributary Capital Management LLC bought a new position in shares of LiveRamp in the 4th quarter valued at $15,251,000. Boston Partners grew its position in LiveRamp by 109.4% during the 4th quarter. Boston Partners now owns 690,057 shares of the company’s stock worth $21,331,000 after acquiring an additional 360,440 shares during the last quarter. Invenomic Capital Management LP increased its holdings in LiveRamp by 257.7% in the 3rd quarter. Invenomic Capital Management LP now owns 337,574 shares of the company’s stock worth $8,365,000 after purchasing an additional 243,198 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in LiveRamp by 30.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 984,040 shares of the company’s stock valued at $29,885,000 after purchasing an additional 230,478 shares during the last quarter. Institutional investors own 93.83% of the company’s stock.
LiveRamp Price Performance
LiveRamp stock opened at $26.33 on Friday. The company’s 50-day moving average is $30.81 and its 200-day moving average is $28.98. The firm has a market capitalization of $1.73 billion, a PE ratio of 2,632.90 and a beta of 0.96. LiveRamp has a fifty-two week low of $21.45 and a fifty-two week high of $38.00.
LiveRamp (NYSE:RAMP – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.22). LiveRamp had a net margin of 0.01% and a return on equity of 0.97%. As a group, analysts expect that LiveRamp will post 0.48 EPS for the current year.
LiveRamp Company Profile
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
Read More
- Five stocks we like better than LiveRamp
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- MarketBeat Week in Review – 03/24 – 03/28
- How to Start Investing in Real Estate
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Airline Stocks – Top Airline Stocks to Buy Now
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for LiveRamp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiveRamp and related companies with MarketBeat.com's FREE daily email newsletter.